Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shufu Chang"'
Autor:
Jingpu Wang, Chenguang Li, Daixin Ding, Mingyou Zhang, Yizhe Wu, Rende Xu, Hao Lu, Zhangwei Chen, Shufu Chang, Yuxiang Dai, Juying Qian, Feng Zhang, Shengxian Tu, Junbo Ge
Publikováno v:
International journal of cardiology. 364
There is a paucity of data comparing functional difference between active jailed balloon technique (A-JBT) and conventional jailed balloon technique (C-JBT) in treating non-left main coronary bifurcation lesions (CBLs).In this retrospective cohort st
Autor:
Shufu Chang, Juying Qian, Junbo Ge, Lu Chen, Mingqiang Fu, Lei Ge, Jianying Ma, Rende Xu, Qing Qin
Publikováno v:
International Journal of Cardiology. 298:18-21
Background Coronary perforation is a serious complication in percutaneous coronary intervention (PCI). In this article, we reported the short and long-term outcomes of patients with coronary perforation managed by coil embolization in our center. Met
Autor:
Yuxiang Dai, Jia Huang, Hao Lu, Zheyong Huang, Juying Qian, Yinyin Chen, Shufu Chang, Lei Ge, Daoyuan Ren, Junbo Ge, Chenguang Li, Feng Zhang
Publikováno v:
International journal of cardiology. 322
Endothelial progenitor cells (EPCs) participate in angiogenesis and neocollateralization. This study assessed if circulating EPCs can predict long-term improvement of global left ventricular systolic function in patients with coronary chronic total o
Publikováno v:
International Journal of Cardiology. 223:98-100
Autor:
Junbo Ge, Shufu Chang, Hang Jin, Juying Qian, Zhangwei Chen, Yunzeng Zou, Jianying Ma, Hong Yun, Aijun Sun
Publikováno v:
International Journal of Cardiology. 167:2278-2284
Objectives This study was designed to evidence the protective effect of glucocorticoid therapy on cardiac dysfunction after coronary microembolization (CME), and to clarify its mechanism with the expression of transforming growth factor-beta 1 (TGF-
Publikováno v:
International Journal of Cardiology. 137:S106
Objective: The aim of this study was to assess the effect of nitroglycerin and verapamil on the coronary flow in patients with the coronary slow flow (CSF) phenomenon (CSFP). Design and methods: Sixty-four patients with CSF and no stenotic lesions du